Vogiatzis Ioannis, Pantzartzidou Alexandra, Pittas Sarantis, Papavasiliou Eleutherios
Smoking Cessation Centre, Department of Cardiology, General Hospital of Veroia, Greece.
Med Arch. 2017 Apr;71(2):128-131. doi: 10.5455/medarh.2017.71.128-131.
Several studies have examined the efficacy of smoking cessation therapies in the general population. However little is known about the efficacy of these advisory methods in cardiovascular patients.
The aim of the study is to determine the prevalence and the characteristics of smoking abstinence in cardiovascular patients, after a smoking intervention during hospitalization.
The study involved 442 patients, smokers admitted for cardiovascular disease to the Department of Cardiology. During hospitalization patient's data were collected and all patients were subjected to a 30-minutes long advisory session with drug administration in selected cases (varenicycline, bupropione, nocitine replacement therapy), according to standard protocol. After the discharge patients were asked about smoking abstinence at time intervals of 24 hours, 1 month, 3, 6 and 12 months.
After hospital discharge 11 patients (2.49%) could not be contacted after several attempts and 19 patients (4.3%) were died during follow up period. A total of 412 patients (218 men and 194 women, mean age 56.49+10.57 years) made up the final study population. Twenty four hours after hospital discharge 364 patients (88.35%) had quitted smoking. At 1, 3, 6 and 12 months the abstinence rates were 70.87%, 64.8%, 55.82% and 47.83% respectively. Patients with ischaemic cardiovascular diseases (angina - infarction) had a significantly higher probability of quitting smoking at 12 months (Hazard ratio: 0.64 - p=0.01).
A smoking cessation program in cardiovascular patients during hospitalization was unlikely to result in success. These patients might benefit by following programs promoting smoking cessation in experienced specialized centers, involving a group of health professionals, such as psychologists and/or trained nurses.
多项研究已考察了戒烟疗法在普通人群中的疗效。然而，对于这些咨询方法在心血管疾病患者中的疗效知之甚少。
本研究旨在确定心血管疾病患者在住院期间接受吸烟干预后戒烟的患病率及特征。
本研究纳入了442名因心血管疾病入住心内科的吸烟患者。住院期间收集患者数据，并根据标准方案，对所有患者进行了30分钟的咨询，并在部分病例中给予药物治疗（伐尼克兰、安非他酮、尼古丁替代疗法）。出院后，每隔24小时、1个月、3个月、6个月和12个月询问患者的戒烟情况。
出院后，经过多次尝试仍有11名患者（2.49%）无法取得联系，19名患者（4.3%）在随访期间死亡。最终的研究人群共有412名患者（218名男性和194名女性，平均年龄56.49±10.57岁）。出院24小时后，364名患者（88.35%）已戒烟。在1个月、3个月、6个月和12个月时，戒烟率分别为70.87%、64.8%、55.82%和47.83%。患有缺血性心血管疾病（心绞痛-心肌梗死）的患者在12个月时戒烟的可能性显著更高（风险比：0.64 - p=0.01）。
心血管疾病患者在住院期间的戒烟计划不太可能成功。这些患者可能会从经验丰富的专业中心开展的、由一组健康专业人员（如心理学家和/或经过培训的护士）参与的促进戒烟计划中受益。
